[12/19 28th Economic Security Study Session] Situation in the Taiwan Strait from the perspective of US-China high-tech friction
The prolonged high-tech friction between the US and China, centered on semiconductors, is increasing tensions in the Taiwan Strait.The Chinese government and industry have placed emphasis on collaborating with Taiwanese companies and human resources in order to expand domestic production of semiconductors, which is a long-awaited goal, but this path was cut short due to sanctions against China by the United States.On the other hand, some believe that Taiwan is using local semiconductor industries such as TSMC as a "silicon shield" to deter China.In this lecture, I will explain the current state and outlook of the high-tech triangle between the United States, China, and Taiwan, taking into account the outcome of Taiwan's presidential election, which will be counted in January next year.
Mari Yamamoto, director of FRONTEO Co., Ltd., will also talk about supply chain analysis examples using FRONTEO AI “KIBIT Seizu Analysis.”
◆ Date: July 2023, 12 (Tuesday) 19: 15-00: 16
◆ Participation conditions: Those who belong to a company
Participants from the same industry, individuals, and free e-mail addresses are not allowed to participate.
He has served as Taipei bureau chief, Asia department deputy director, and China director general at Nihon Keizai Shimbun, and also served as a researcher at the Japan Economic Research Center before assuming his current position in April 2023.Co-authored works include ``Economic Security in Asia: Structure of a New Power Game'' (Nihon Keizai Shimbun Publishing) and ``Inspection of the Xi Jinping Administration: Challenges and Prospects Facing the Long-term Administration'' (Bunshindo).He graduated from the Department of Political Science and Economics at Waseda University and completed an EMBA for foreign companies at Peking University.
Mari Yamamoto
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnosis support and disease prediction using the AI engine "KIBIT".In the drug discovery field, we will greatly improve the efficiency of drug discovery research by fusing AI and drug discovery experts.・Develop business that supports acceleration and improvement of success rate, and challenge new areas in life science.
In the business intelligence business, he uses KIBIT to lead corporate DX promotion support.We will also develop AI-based solutions in the economic security field to support governments, public offices, and companies.
Articles in the same category
[Online seminar held on 5/23] Extraterritorial application of law - Practical impact of new US regulatory reforms on non-US companies -
Analyzing the classification results of sarcopenia-related papers by AI - I tried using paper search AI -
[Online seminar held on 5/30] Practical techniques for legal due diligence for M&A
[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis
[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -
Parkinson's disease - Analyzing drug discovery targets using paper search AI